Effects of High Dose Statin Therapy (FDG)/Atheroscleroti

ID Number 08-0549

Principal Investigator(s)
Michael E Farkouh

Department(s) or Division(s)

Research Entity
The Zena and Michael A. Wiener Cardiovascular Institute

The purpose of this study is to evaluate the utility of 18 FDG-PET as a tool to quantify atherosclerotic plaque. ClinicalTrials.gov Identifier: NCT00703261

Contact Information
Kshitij Shah
(212) 659-8847

Recruiting Patients: No